HSA — authorised 3 July 1979
- Marketing authorisation holder: JACOBUS
- Status: likely_approved
HSA authorised Aczone on 3 July 1979
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 3 July 1979; HSA authorised it on 4 April 2025; HSA authorised it on 23 April 2025.
JACOBUS holds the Singaporean marketing authorisation.